| scholarly article | Q13442814 |
| P50 | author | Ka Fai To | Q99551275 |
| P2093 | author name string | Philip J Johnson | |
| Y M Dennis Lo | |||
| K C Allen Chan | |||
| Anthony T C Chan | |||
| Lisa Y S Chan | |||
| Sing-Fai Leung | |||
| Edward W H To | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 3254-3259 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma | |
| P478 | volume | 9 |
| Q26800017 | A Review: Proteomics in Nasopharyngeal Carcinoma |
| Q35741860 | A novel approach for determining cancer genomic breakpoints in the presence of normal DNA |
| Q33797039 | Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients |
| Q47136367 | Cell-Free DNA Kinetics in a Pre-Clinical Model of Head and Neck Cancer |
| Q26750899 | Cell-free circulating tumor DNA in cancer |
| Q36610034 | Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers |
| Q41547611 | Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer |
| Q42375480 | Clinical outcomes of residual or recurrent nasopharyngeal carcinoma treated with endoscopic nasopharyngectomy plus chemoradiotherapy or with chemoradiotherapy alone: a retrospective study |
| Q33709895 | Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer |
| Q64066848 | Clinical utility of circulating tumor DNA for colorectal cancer |
| Q35001628 | Clonal immunoglobulin DNA in the plasma of patients with AIDS lymphoma |
| Q59358708 | Decreased oral Epstein-Barr virus DNA loads in patients with nasopharyngeal carcinoma in Southern China: A case-control and a family-based study |
| Q64899007 | Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA). |
| Q33218405 | Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia |
| Q35543094 | Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathology |
| Q52679757 | Dynamic changes in plasma Epstein-Barr virus DNA load during treatment have prognostic value in nasopharyngeal carcinoma: a retrospective study. |
| Q50043988 | Dynamic changes of circulating tumour DNA in surgical lung cancer patients: protocol for a prospective observational study |
| Q33873153 | Endoplasmic reticulum stress pathway PERK-eIF2α confers radioresistance in oropharyngeal carcinoma by activating NF-κB. |
| Q89776850 | Epstein-Barr virus DNA in serum as an early prognostic marker in children and adolescents with Hodgkin lymphoma |
| Q36229421 | Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study |
| Q34500078 | Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer |
| Q38438570 | IKKα-mediated biogenesis of miR-196a through interaction with Drosha regulates the sensitivity of cancer cells to radiotherapy |
| Q36642753 | Identification of ERp29 as a biomarker for predicting nasopharyngeal carcinoma response to radiotherapy |
| Q47563363 | Incorporating Blood-based Liquid Biopsy Information into Cancer Staging: Time for a TNMB System? |
| Q55054174 | Inhibiting ERp29 expression enhances radiosensitivity in human nasopharyngeal carcinoma cell lines. |
| Q37192117 | Laboratory assays for Epstein-Barr virus-related disease |
| Q36335515 | Levels of plasma Epstein-Barr virus DNA prior and subsequent to treatment predicts the prognosis of nasopharyngeal carcinoma |
| Q39149201 | Liquid biopsies come of age: towards implementation of circulating tumour DNA. |
| Q55187959 | Liquid biopsy in pancreatic cancer: the beginning of a new era. |
| Q90569462 | Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review |
| Q34520470 | Phase I clinical trial of valacyclovir and standard of care cyclophosphamide in children with endemic Burkitt lymphoma in Malawi |
| Q38270678 | Plasma Epstein-Barr virus DNA as a biomarker for nasopharyngeal carcinoma |
| Q36305182 | Positivity of both plasma Epstein-Barr virus DNA and serum Epstein-Barr virus capsid specific immunoglobulin A is a better prognostic biomarker for nasopharyngeal carcinoma |
| Q57253775 | Proceedings of the 10th Asian Pacific Congress of Clinical Biochemistry in conjunction with the Australasian Association of Clinical Biochemists' 42nd Annual Scientific Conference |
| Q99711993 | Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy |
| Q37706344 | Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma |
| Q52647899 | Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma. |
| Q38919733 | Rapid Detection of Cell-Free Mycobacterium tuberculosis DNA in Tuberculous Pleural Effusion |
| Q90051001 | Reducing Ovarian Cancer Mortality Through Early Detection: Approaches Using Circulating Biomarkers |
| Q58093740 | Relationship between pretreatment concentration of plasma Epstein-Barr virus DNA and tumor burden in nasopharyngeal carcinoma: An updated interpretation |
| Q54340242 | Role of circulating tumor DNA in the management of early-stage lung cancer. |
| Q37729875 | Selection of reliable reference genes for gene expression study in nasopharyngeal carcinoma |
| Q36892139 | The Epstein Barr virus DNA levels as a tumor marker in EBV-associated cancers. |
| Q48143437 | The Value of Cell-free DNA for Molecular Pathology |
| Q36152889 | The clinical utility of plasma Epstein-Barr virus DNA assays in nasopharyngeal carcinoma: the dawn of a new era?: a systematic review and meta-analysis of 7836 cases |
| Q64078507 | The emerging role of cell-free DNA as a molecular marker for cancer management |
| Q38440804 | The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma |
| Q64932561 | miR‑495 enhances the efficacy of radiotherapy by targeting GRP78 to regulate EMT in nasopharyngeal carcinoma cells. |
Search more.